Volatile Stocks: Advaxis (NASDAQ:ADXS), Ligand Pharmaceuticals (NASDAQ:LGND), ANI Pharmaceuticals (NASDAQ:ANIP), La Jolla Pharmaceutical Co. (NASDAQ:LJPC), Alcobra (NASDAQ:ADHD)

On 28 January, Securities lawyers at Dunnam & Dunnam are investigating allegations for Advaxis, Inc. shareholders (NASDAQ:ADXS). Concerned ADXS investors who purchased between January 7, 2015 and January 20, 2015 are encouraged to contact securities attorney Hamilton Lindley. On Monday shares of Advaxis, Inc. (NASDAQ:ADXS) closed at $7.31.

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) reported Total revenues for the fourth quarter of 2014 were $23.0 million, an increase of 56% compared with $14.7 million for the same period in 2013. Royalty revenues increased 32% to $9.4 million from $7.1 million for the same period in 2013, primarily due to higher royalties from Promacta® and Kyprolis®. Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) in last trading activity decreased -0.80% to close at $54.55. Company weekly performance is -1.27% while its quarterly performance stands at -0.66%. Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) is -32.17% away from its 52 week high.

On 3 February, ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced the promotion of David J. Sullivan, Ph.D. to the position of Vice President, Quality Operations. Dr. Sullivan joined ANI in April 2014 from Boston Scientific where he was responsible for cGMP laboratories, quality engineering, and systems. On last trading day ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) moved up 7.18% to close at $59.28. Its volatility for the week is 6.79% while volatility for the month is 5.39%. ANIP’s sales growth for past 5 years was 51.30% and its EPS growth for past 5 years was 47.00%. ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) monthly performance is 5.61%.

La Jolla Pharmaceutical (NASDAQ:LJPC) reported it reached an agreement with the U.S. FDA on a Special Protocol Assessment for its Phase 3 clinical trial of LJPC-501 for the treatment of catecholamine-resistant hypotension. La Jolla Pharmaceutical Co. (NASDAQ:LJPC) has 9.30% insider ownership while its institutional ownership stands at 53.70%. In last trading activity company’s stock closed at $18.32.

Alcobra Ltd. (NASDAQ:ADHD) announced that it will report its financial results for the fourth quarter and fiscal year ended December 31, 2014 before the market open, and will host a corporate update conference call and webcast on Thursday, February 12 at 8:30am Eastern Time. On last trading day Alcobra Ltd. (NASDAQ:ADHD) decreased -3.88% to close at $6.19. Its volatility for the week is 11.09% while volatility for the month is 13.72%. Alcobra Ltd. (NASDAQ:ADHD) monthly performance is 45.65%.

Leave a Reply

Your email address will not be published. Required fields are marked *